Sun N, Ogulur I, Mitamura Y, Yazici D, Pat Y, Bu X
Allergy. 2024; 79(12):3192-3237.
PMID: 39370939
PMC: 11657050.
DOI: 10.1111/all.16318.
Singh Y, Trautwein C, Romani J, Salker M, Neckel P, Fraccaroli I
Mol Neurodegener. 2023; 18(1):44.
PMID: 37403161
PMC: 10318726.
DOI: 10.1186/s13024-023-00628-1.
Montanari M, Imbriani P, Bonsi P, Martella G, Peppe A
Biomedicines. 2023; 11(6).
PMID: 37371655
PMC: 10295288.
DOI: 10.3390/biomedicines11061560.
Stegemann L, Neufeld P, Hecking I, Vorgerd M, Matschke V, Stahlke S
Cells. 2023; 12(8).
PMID: 37190115
PMC: 10137066.
DOI: 10.3390/cells12081206.
Jotanovic J, Milin-Lazovic J, Alafuzoff I
J Neuropathol Exp Neurol. 2022; 81(5):356-362.
PMID: 35388426
PMC: 9041339.
DOI: 10.1093/jnen/nlac023.
Colonic Leucine-Rich Repeat Kinase 2 Expression Is Increased and Associated With Disease Severity in Patients With Parkinson's Disease.
Liao P, Chiang H, Shun C, Hang J, Chiu H, Wu M
Front Aging Neurosci. 2022; 13:819373.
PMID: 35126095
PMC: 8812574.
DOI: 10.3389/fnagi.2021.819373.
Gender Was Associated with Depression but Not with Gastrointestinal Dysfunction in Patients with Parkinson's Disease.
Xiao-Ling Q, Yin-Zhen D, Xue-Kui L, Xue L, Gang C, Zai-Li L
Parkinsons Dis. 2022; 2021:3118948.
PMID: 34976368
PMC: 8716198.
DOI: 10.1155/2021/3118948.
Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson's Disease.
Marie A, Darricau M, Touyarot K, Parr-Brownlie L, Bosch-Bouju C
J Parkinsons Dis. 2021; 11(3):949-970.
PMID: 34120916
PMC: 8461657.
DOI: 10.3233/JPD-212671.
Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells.
Goveas L, Mutez E, Chartier-Harlin M, Taymans J
Cells. 2021; 10(5).
PMID: 33922322
PMC: 8145309.
DOI: 10.3390/cells10050981.
Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease.
Benvenuti L, DAntongiovanni V, Pellegrini C, Antonioli L, Bernardini N, Blandizzi C
Int J Mol Sci. 2020; 21(23).
PMID: 33276665
PMC: 7730281.
DOI: 10.3390/ijms21239199.
Detection of Phosphorylated Alpha-Synuclein in the Muscularis Propria of the Gastrointestinal Tract Is a Sensitive Predictor for Parkinson's Disease.
Beck G, Hori Y, Hayashi Y, Morii E, Takehara T, Mochizuki H
Parkinsons Dis. 2020; 2020:4687530.
PMID: 33029342
PMC: 7530470.
DOI: 10.1155/2020/4687530.
A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.
Hendrickx D, Garcia P, Ashrafi A, Sciortino A, Schmit K, Kollmus H
Mol Neurobiol. 2020; 58(2):576-602.
PMID: 32997293
PMC: 8219584.
DOI: 10.1007/s12035-020-02085-z.
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis.
Sheng L, Stewart T, Yang D, Thorland E, Soltys D, Aro P
Acta Neuropathol Commun. 2020; 8(1):102.
PMID: 32641150
PMC: 7346449.
DOI: 10.1186/s40478-020-00983-w.
Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.
Kim Y, Lee C, Kim S, Jang J, Lee S, Lee S
J Neurol. 2019; 267(2):513-521.
PMID: 31691020
DOI: 10.1007/s00415-019-09617-1.
"Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome?.
Liebert A, Bicknell B, Johnstone D, Gordon L, Kiat H, Hamblin M
Photobiomodul Photomed Laser Surg. 2019; 37(11):681-693.
PMID: 31596658
PMC: 6859693.
DOI: 10.1089/photob.2019.4628.
Leucine-Rich Repeat Kinase 2 Is Associated With Activation of the Paraventricular Nucleus of the Hypothalamus and Stress-Related Gastrointestinal Dysmotility.
Maekawa T, Tsushima H, Kawakami F, Kawashima R, Kodo M, Imai M
Front Neurosci. 2019; 13:905.
PMID: 31555076
PMC: 6727664.
DOI: 10.3389/fnins.2019.00905.
Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
Chiang H, Lin C
J Mov Disord. 2019; 12(2):67-83.
PMID: 31158941
PMC: 6547039.
DOI: 10.14802/jmd.18067.
Analysis of the clinical features of early Parkinson's disease with comparatively integrated intestinal function.
Guan X, Wang Y, Li Q, Wei M, Chen L, Cheng O
Neurol Sci. 2018; 39(11):1847-1856.
PMID: 30019200
DOI: 10.1007/s10072-018-3502-3.
Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease.
Yan F, Chen Y, Li M, Wang Y, Zhang W, Chen X
Medicine (Baltimore). 2018; 97(28):e11337.
PMID: 29995769
PMC: 6076112.
DOI: 10.1097/MD.0000000000011337.
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
Palma J, Kaufmann H
Mov Disord. 2018; 33(3):372-390.
PMID: 29508455
PMC: 5844369.
DOI: 10.1002/mds.27344.